MetLife Growth Series last-minute Real Value cannot be determined due to lack of data. The latest price of MetLife Growth Series is 0.0. Based on Macroaxis valuation methodology, the organization cannot be evaluated at this time. We determine the value of MetLife Growth Series from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we recommend to purchase undervalued stocks and to get rid of overvalued stocks since at some point entities prices and their ongoing real values will merge together.
|Horizon||30 Days Login to change|
MetLife Growth Series 1 is currently considered the top fund in five year return among similar funds. It is currently considered the top fund in three year return among similar funds reporting about 0.94 of Three Year Return per Five Year Return. The ratio of Five Year Return to Three Year Return for MetLife Growth Series 1 is roughly 1.07
|Five Year Return ( % )|